Center Book Partners LP Humacyte, Inc. Transaction History
Center Book Partners LP
- $1.83 Billion
- Q3 2025
A detailed history of Center Book Partners LP transactions in Humacyte, Inc. stock. As of the latest transaction made, Center Book Partners LP holds 283,627 shares of HUMA stock, worth $334,679. This represents 0.03% of its overall portfolio holdings.
Number of Shares
283,627
Previous 3,430,255
91.73%
Holding current value
$334,679
Previous $7.17 Million
93.12%
% of portfolio
0.03%
Previous 0.42%
Shares
7 transactions
Others Institutions Holding HUMA
# of Institutions
156Shares Held
43.2MCall Options Held
383KPut Options Held
490K-
Vanguard Group Inc Valley Forge, PA7.52MShares$8.87 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.14MShares$8.43 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.1MShares$3.65 Million0.0% of portfolio
-
State Street Corp Boston, MA2.41MShares$2.84 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.1MShares$2.47 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $122M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...